166 related articles for article (PubMed ID: 23371545)
1. Validation of NIH consensus criteria for diagnosis and severity-grading of chronic graft-versus-host disease.
Aisa Y; Mori T; Kato J; Yamane A; Kohashi S; Kikuchi T; Okamoto S
Int J Hematol; 2013 Feb; 97(2):263-71. PubMed ID: 23371545
[TBL] [Abstract][Full Text] [Related]
2. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of NIH consensus criteria for chronic graft-versus-host disease.
Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC
Leukemia; 2009 Jan; 23(1):78-84. PubMed ID: 18830253
[TBL] [Abstract][Full Text] [Related]
4. Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD.
Kim DY; Lee JH; Lee JH; Kim SH; Lim SN; Kim SD; Choi Y; Lee YS; Kang YA; Kang SI; Seol M; Ryu SG; Lee KH
Bone Marrow Transplant; 2010 Jul; 45(7):1174-80. PubMed ID: 19915630
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria.
Sato T; Ichinohe T; Kanda J; Yamashita K; Kondo T; Ishikawa T; Uchiyama T; Takaori-Kondo A
Int J Hematol; 2011 Apr; 93(4):532-541. PubMed ID: 21465116
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.
Vigorito AC; Campregher PV; Storer BE; Carpenter PA; Moravec CK; Kiem HP; Fero ML; Warren EH; Lee SJ; Appelbaum FR; Martin PJ; Flowers ME;
Blood; 2009 Jul; 114(3):702-8. PubMed ID: 19470693
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of the NIH consensus criteria in children with chronic graft-versus-host disease.
Lee JW; Lee DH; Jang PS; Yi MS; Chung NG; Cho B; Jeong DC; Kim HK
Yonsei Med J; 2011 Sep; 52(5):779-86. PubMed ID: 21786443
[TBL] [Abstract][Full Text] [Related]
8. National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen.
Saillard C; Crocchiolo R; Furst S; El-Cheikh J; Castagna L; Signori A; Oudin C; Faucher C; Lemarie C; Chabannon C; Granata A; Blaise D
Leuk Lymphoma; 2014 May; 55(5):1106-12. PubMed ID: 23822538
[TBL] [Abstract][Full Text] [Related]
9. Response and survival of patients with chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications.
Del Fante C; Scudeller L; Viarengo G; Bernasconi P; Perotti C
Transfusion; 2012 Sep; 52(9):2007-15. PubMed ID: 22320219
[TBL] [Abstract][Full Text] [Related]
10. A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort.
Ohwada C; Sakaida E; Igarashi A; Kobayashi T; Doki N; Mori T; Kato J; Koda Y; Kanamori H; Tanaka M; Tachibana T; Fujisawa S; Nakajima Y; Numata A; Toyosaki M; Aoyama Y; Onizuka M; Hagihara M; Koyama S; Kanda Y; Nakasone H; Shimizu H; Kato S; Watanabe R; Shono K; Sakai R; Saito T; Nakaseko C; Okamoto S
Biol Blood Marrow Transplant; 2020 Jan; 26(1):162-170. PubMed ID: 31536824
[TBL] [Abstract][Full Text] [Related]
11. The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality.
Pidala J; Kim J; Anasetti C; Nishihori T; Betts B; Field T; Perkins J
Haematologica; 2011 Nov; 96(11):1678-84. PubMed ID: 21791465
[TBL] [Abstract][Full Text] [Related]
12. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.
Jagasia M; Giglia J; Chinratanalab W; Dixon S; Chen H; Frangoul H; Engelhardt B; Goodman S; Greer J; Kassim A; Morgan D; Ruffner K; Schuening F
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1207-15. PubMed ID: 17889358
[TBL] [Abstract][Full Text] [Related]
13. The National Institutes of Health criteria for classification and scoring of chronic graft versus host disease: long-term follow-up of a single center series.
Tecchio C; Mosna F; Andreini A; Paoli L; Di Bella R; de Sabata D; Sorio M; Pizzolo G; Benedetti F
Leuk Lymphoma; 2013 May; 54(5):1020-7. PubMed ID: 23035648
[TBL] [Abstract][Full Text] [Related]
14. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.
Filipovich AH; Weisdorf D; Pavletic S; Socie G; Wingard JR; Lee SJ; Martin P; Chien J; Przepiorka D; Couriel D; Cowen EW; Dinndorf P; Farrell A; Hartzman R; Henslee-Downey J; Jacobsohn D; McDonald G; Mittleman B; Rizzo JD; Robinson M; Schubert M; Schultz K; Shulman H; Turner M; Vogelsang G; Flowers ME
Biol Blood Marrow Transplant; 2005 Dec; 11(12):945-56. PubMed ID: 16338616
[TBL] [Abstract][Full Text] [Related]
15. Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria.
Cuvelier GDE; Nemecek ER; Wahlstrom JT; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Flower A; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savaşan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; West LJ; Pan B; Al Hamarneh YN; Halevy A; Schultz KR
Blood; 2019 Jul; 134(3):304-316. PubMed ID: 31043425
[TBL] [Abstract][Full Text] [Related]
16. Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomes.
Cho BS; Lee SE; Song HH; Lee JH; Yahng SA; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1136-43. PubMed ID: 22261380
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.
Flowers ME; Inamoto Y; Carpenter PA; Lee SJ; Kiem HP; Petersdorf EW; Pereira SE; Nash RA; Mielcarek M; Fero ML; Warren EH; Sanders JE; Storb RF; Appelbaum FR; Storer BE; Martin PJ
Blood; 2011 Mar; 117(11):3214-9. PubMed ID: 21263156
[TBL] [Abstract][Full Text] [Related]
18. Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study.
Kuzmina Z; Eder S; Böhm A; Pernicka E; Vormittag L; Kalhs P; Petkov V; Stary G; Nepp J; Knobler R; Just U; Krenn K; Worel N; Greinix HT
Leukemia; 2012 Apr; 26(4):746-56. PubMed ID: 21926960
[TBL] [Abstract][Full Text] [Related]
19. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.
Arai S; Jagasia M; Storer B; Chai X; Pidala J; Cutler C; Arora M; Weisdorf DJ; Flowers ME; Martin PJ; Palmer J; Jacobsohn D; Pavletic SZ; Vogelsang GB; Lee SJ
Blood; 2011 Oct; 118(15):4242-9. PubMed ID: 21791424
[TBL] [Abstract][Full Text] [Related]
20. Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric.
Rapoport Y; Freeman T; Koyama T; Engelhardt BG; Jagasia M; Savani BN; Tran U; Kassim AA
Cornea; 2017 Feb; 36(2):258-263. PubMed ID: 28060078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
